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How the kidney prevents urinary excretion of plasma proteins
continues to be debated. Here, using unfixed whole-mount mouse
kidneys, we show that fluorescent-tagged proteins and neutral
dextrans permeate into the glomerular basement membrane (GBM),
in general agreement with Ogston’s 1958 equation describing how
permeation into gels is related to molecular size. Electron-microscopic
analyses of kidneys fixed seconds to hours after injecting gold-tagged
albumin, negatively charged gold nanoparticles, and stable oligoclus-
ters of gold nanoparticles show that permeation into the lamina densa
of the GBM is size-sensitive. Nanoparticles comparable in size with IgG
dimers do not permeate into it. IgG monomer-sized particles permeate
to some extent. Albumin-sized particles permeate extensively into the
lamina densa. Particles traversing the lamina densa tend to accumulate
upstream of the podocyte glycocalyx that spans the slit, but none are
observed upstream of the slit diaphragm. At low concentrations, oval-
bumin-sized nanoparticles reach the primary filtrate, are captured by
proximal tubule cells, and are endocytosed. At higher concentrations,
tubular capture is saturated, and they reach the urine. In mousemodels
of Pierson’s or Alport’s proteinuric syndromes resulting from defects in
GBM structural proteins (laminin β2 or collagen α3 IV), the GBM is
irregularly swollen, the lamina densa is absent, and permeation is in-
creased. Our observations indicate that size-dependent permeation in-
to the lamina densa of the GBM and the podocyte glycocalyx, together
with saturable tubular capture, determines which macromolecules
reach the urine without the need to invoke direct size selection by
the slit diaphragm.
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More than 50 y ago, Lathe and Ruthven described how thedifferential penetrance into swollen starch grains packed in a
column could be used to separate substances in a size-dependent
manner (1). Shortly thereafter, Ogston derived a simple equation
relating the space available to molecules of differing sizes in a ran-
dom network of fibers (2). More recently, Bosma and Wesselingh
have rederived and extended Ogston’s equation and have demon-
strated its ability to describe the size-dependent permeation of a
large range of macromolecules into a wide variety of gels (3). Sub-
sequently, one of us hypothesized that excretion of proteins by the
kidney is limited because macromolecules are excluded from the gel-
like glomerular basement membrane (GBM) in proportion to their
sizes and because most filtered macromolecules are removed by
tubules unless capture is saturated (4).
Here, we tested this hypothesis by using confocal microscopy and
transmission electron microscopy (TEM) to determine the perme-
ation into the GBM and the subsequent fates of molecules of dif-
fering hydrodynamic radii. The confocal experiments showed that
permeation into the GBM decreases as hydrodynamic size increases,
in general agreement with Smithies/Ogston expectations. The TEM
experiments, which enable quantification of the permeation into the
different parts of the GBM, demonstrated the importance of the
lamina densa and the podocyte glycocalyx in size selection and
showed that small particles that can pass through the glomerulus are
captured by proximal tubule cells and do not reach the urine unless
this capture is saturated. Particles were observed at the luminal side
of the podocyte glycocalyx, but none were seen adjacent to the slit
diaphragm. In mouse models of Pierson’s and Alport’s syndromes,
absence of either laminin β2 or collagen α3(IV) allowed the GBM to
swell, precluded formation of a lamina densa, and increased per-
meation. We conclude that size-dependent permeation into the
GBM and the podocyte glycocalyx, combined with saturable tubular
capture of filtered macromolecules, determines whether macro-
molecules reach the urine. The slit diaphragm is essential for cap-
illary structure but is probably not a direct determinant of glomerular
size selectivity.
Results
Permeation into the GBM and Subsequent Fate of Fluorescent
Macromolecules. Initial tests used confocal microscopy to de-
termine the distribution in the kidney of fluorescent-tagged 12-kDa
parvalbumin, 45-kDa ovalbumin, and 66-kDa BSA 2 min after their
injection as a mixture into the tail veins of young adult male mice.
The intensities of parvalbumin fluorescence in the GBM and in the
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plasma were almost equal (Fig. 1A), indicating essentially un-
restricted permeation into the GBM. The intensity of ovalbumin
fluorescence in the GBM (Fig. 1B) was clearly less, and that of BSA
was much less (Fig. 1C), demonstrating that permeation into the
GBM is reduced as protein size increases. In Fig. 1A, parvalbumin
fluorescence in the intracellular vesicles of the tall epithelial cells of a
downstream proximal tubule (PT) is much brighter than in the GBM
or the plasma, showing that substantial amounts of parvalbumin
have passed through the glomerulus and have been captured by the
tubules in the 2 min since the proteins were injected. In Fig. 1B,
ovalbumin fluorescence in the GBM is less than that of parvalbumin
although ovalbumin has still traversed the glomerulus and has been
concentrated into intracellular vesicles within the proximal tubule
cells. In Fig. 1C, no albumin fluorescence is visible in the tubules.
Nevertheless, in other experiments, in which the kidneys were har-
vested from mice 15 min after injection, fluorescent-tagged BSA and
IgG were detected in the intracellular vesicles of the proximal tu-
bules, showing that glomerular filtration and tubular capture of these
larger proteins occur, although detecting this capture requires a
longer time of accumulation.
Both parvalbumin and ovalbumin were excreted in the urine
(Fig. 1D), indicating that their capture by the proximal tubules
was saturated. Interestingly, gel electrophoresis showed that the
proteins in the urine at the early times were largely intact, but at
the later times they were degraded. Far less fluorescent BSA was
excreted, suggesting that tubular capture was adequate to cap-
ture the smaller amounts of this protein that had passed through
the GBM.
The results of extensive measurements in unfixed whole-mount
kidney preparations of the ratios of the intensities of fluorescence
in the GBM and plasma (GBM/plasma intensities) of four
fluorescent-tagged proteins and three fluorescent-tagged neutral
dextrans are presented graphically in Fig. 1E (SI Materials and
Methods, Whole-Mount Fluorescence Measurements). The panel is
a plot of the natural logarithm of the experimentally determined
ratios versus Ogston’s variable (R + r)2, where “R” is the hydro-
dynamic radius of the tested macromolecules and “r” is an as-
sumed radius for the fibers comprising the gel (2, 4). The best fit
line drawn through the experimental points accounts for 94% of
the variance in the observed GBM/plasma ratios (R2 = 0.94). We
conclude that the concentrations in the GBM of the test molecules
(including uncharged dextrans) are in general agreement with
Ogston’s permeation equation although the GBM/plasma ratios
are large, ∼0.20 for albumin and ∼0.08 for 70-kDa dextran, be-
cause permeation into the lamina rara interna is only modestly
restricted, as we show in Size Discrimination by the GBM, and
because this region contributes most to the GBM fluorescence.
Note that many of the glomerular capillaries in these images are
devoid of plasma (Fig. 1A, asterisks). Instead, the capillary space is
occupied by packed red cells or by the bodies of podocytes, en-
dothelial cells, or mesangial cells (Figs. S1 and S2 and Table S1).
Plasma retention was partially but never completely improved by
injecting fixative under the kidney capsule before excision of the
organ, as described by Farquhar et al., who had encountered the
same problem (5).
Permeation of Gold-Tagged Albumin into the GBM. To better un-
derstand the events occurring in the GBM, we used transmission
electron microscopy (TEM) to follow the fate of injected gold-
tagged albumin and a variety of gold nanoparticles. This procedure
required achieving a high concentration of particles in the glomer-
ular capillaries, which we obtained by injecting them retrogradely
via the superior mesenteric artery (SI Materials and Methods). Fig.
2A shows an Ag-enhanced TEM image obtained after arterial in-
jection of mouse serum albumin tagged with 1.4-nm diameter gold
nanoparticles (average ratio, one nanoparticle per albumin mole-
cule). The gold-tagged mouse albumin is apparent in the plasma,
but none is apparent in the GBM. Because the area of the GBM in
the image is approximately one tenth the area of the plasma, this
image shows that the GBM/plasma ratio for the tagged albumin was
≤0.1. To refine this estimate, we prepared two types of gold
nanoparticles that are comparable with plasma proteins in hydro-
dynamic sizes and that do not agglutinate when administered at the
high concentrations needed for counting macromolecules in regions
within the GBM where permeation is low.
Sodium Borohydride Nanoparticles and Sodium Thiocyanate
Oligoclusters. Sodium borohydride (NaBH4) nanoparticles proved
useful when made with hydrodynamic sizes up to that of ovalbu-
min (molecular mass 45 kDa); above that size, the preparations
precipitated on storage. These near spherical nanoparticles were
prepared (SI Materials and Methods) by a two-step alkaline re-
duction of 1 mM aqueous gold chloride—first with 3 mM or 5 mM
DTT, then with 4 mM NaBH4. They are stable in PBS made
without calcium or magnesium but tend to irreversibly aggregate
when at high concentrations in plasma or in PBS containing the
divalent cations.
Sodium thiocyanate (NaSCN) oligoclusters proved useful when
made in hydrodynamic sizes ranging from as small as albumin
(molecular mass 66 kDa) to larger than IgG dimers (molecular
mass 300 kDa). These oligoclusters were prepared by making
1 mM aqueous gold chloride alkaline, followed by adding the re-
ductant, 10 mM NaSCN, after various delay times (6, 7). The oli-
goclusters, which are like bunches of grapes, comprise subunits
ranging in number from 1 to over 50, the number being controlled
by varying the delay time from less than a second to several hours.
Once made, the oligoclusters are extremely stable. They have no
tendency to aggregate even when at extremely high concentrations
in plasma or PBS (6).
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Fig. 1. The GBM/plasma ratio decreases as molecular size increases in general
agreement with Ogston’s equation; filtered proteins are captured by the
proximal tubule, but some reach the urine. (A–C) Confocal images at appro-
priate wavelengths of a glomerulus in a paraformaldehyde-fixed kidney of a
male mouse killed 2 min after tail-vein injection of parvalbumin (488 nm flu-
orophore), ovalbumin (555 nm), and BSA (647 nm). The overall brightness of
the images has been adjusted so that the fluorescences for the three fluo-
rophores are equal in a capillary that contains plasma (dotted square boxes).
Many capillaries are devoid of plasma (asterisks) for reasons detailed in Fig. S2.
The brush border of a proximal tubule is indicated with an arrow. The base-
ment membrane of Bowman’s capsule is indicatedwith an arrowhead. (D) Time
course of the urinary concentration of the three proteins relative to their
concentrations in the injected mixture. (E) Logarithmic plot of the GBM/plasma
fluorescence intensities, measured in whole-mount unfixed kidneys, for four
proteins and three dextrans versus the simple function, (R + 0.75)2, of their
hydrodynamic radii (R) expected from Ogston’s equation (2, 4); molecular
masses and Stokes/Einstein hydrodynamic radii are listed in the Inset.
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Both types of particles were coated with glutathione (GSH). The
gold cores of the NaBH4 particles have sharp outlines. The out-
lines of the NaSCN subunits are fuzzy, showing that they have a
gold-containing fringe, which may account for their resistance to
aggregation. When necessary for visualization in the TEM at lower
magnifications, the gold cores of the NaBH4 nanoparticles (but not
the cores of the NaSCN oligoclusters) could be increased in size by
enhancement with Ag before embedding, or, more conveniently,
by Au enhancing ultrathin sections of London Resin (LR) white-
embedded Karnovsky-fixed kidney samples on nickel grids.
The NaBH4 Nanoparticles and NaSCN Oligoclusters Bind to a Component
of the GBM Close to the Bases of the Podocyte Foot Processes. Fig. 2B
shows an enhanced TEM image of a glomerular capillary after
intraarterially injecting NaBH4 nanoparticles comparable in size
with ovalbumin, followed immediately by subcapsular injection of a
fixative. As expected, these small nanoparticles permeated easily
into the GBM. However, unexpectedly, many of them appeared at
a high concentration close to the bases of the podocyte foot pro-
cesses. Unenhanced images at a higher magnification show that
these podocyte-associated particles (PAPs) are not directly adja-
cent to the plasma membrane of the podocytes (Fig. 2C); rather,
they seem to be bound to a component of the GBM an appreciable
distance upstream. NaSCN particles of a comparable size behave
similarly (Fig. 2D). The size distribution of the PAPs differs from
that of particles in the adjoining plasma (Fig. 2 E and E, Inset)—
larger NaBH4 particles are overrepresented even though we show
in Size Discrimination by the GBM that permeation into the GBM
favors smaller particles. The PAPs appear as a monomolecular line
at the bases of the podocyte foot processes when viewed in cross-
section (blue arrows in Fig. 2F), but oblique views show that they
are actually a layer (red arrows in Fig. 2F).
Heparin Inhibits the Binding of the Particles to the GBM. Because
both the NaBH4 nanoparticles and the NaSCN oligoclusters have
a high negative charge as a result of their GSH coats, we tested
whether the binding might be blocked or reversed with heparin
(which also has a high negative charge at physiological pHs), which
proved to be the case. The usual binding (Fig. S3A) was completely
blocked if 400 international units (I.U.) of heparin was injected via
the tail vein before giving the particles (Fig. S3B). Likewise, hep-
arin completely displaced the bound particles when given after the
particles (Fig. S3C). The PAPs are so prevalent that further in-
vestigation is warranted to determine their relevance to normal
glomerular function and their eventual fates.
Aggregates of NaBH4 Nanoparticles Formed in Vivo. When small
NaBH4 nanoparticles were injected at high concentrations, the
PAPs tended to form aggregates that were frequently observed at
the entrance to the podocyte slits (Fig. 3A, black arrows), and less
frequently at other sites along the bases of the podocyte foot
processes (Fig. 3A, white arrow). (NaSCN oligoclusters did not
form aggregates.) The number of particles in the aggregates varied
from a few to more than 20. The aggregates were widely spaced
along the slits (Fig. 3 B and C). The plane in which the aggregates
located is highly informative. Thus, both the aggregates (Fig. 3D)
and the individual particles (Fig. 3E) remaining in the glomerular
capillaries an hour postinjection were in a plane that is clearly well
upstream of the slit diaphragm, possibly at the luminal surface of
the glycocalyx, which is present over the surfaces of the bases of
the podocytes and covers the podocyte slits (8). Individual parti-
cles or aggregates of particles did not accumulate close to the slit
diaphragm. The PAPs are persistent because they were still pre-
sent in images obtained 2 and 4 h after the injection, at which
times the plasma is virtually devoid of particles. No particles were
seen within the podocytes at any time, indicating that they were
not endocytosed by the podocytes. The PAPs did not dissociate
easily because they were also present in kidneys that had been
extensively perfused with room temperature PBS delivered from
the heart, starting a few minutes after the injection.
Together, these results suggest that the aggregated PAPs
cannot penetrate the glycocalyx of the podocytes but are swept to
the podocyte slits by the tangential movement of fluid in the
lamina rara externa, which is on its way to leaving the glomerulus
via the slits. The PAPs are not endocytosed by the podocytes and
remain for hours in a layer well upstream of the slit diaphragm.
Fig. 2. Permeation of gold-tagged albumin and nanoparticles into the GBM
and accumulation in a layer close to the bases of podocyte foot processes.
(A) Enhanced TEM image of a glomerular capillary fixed immediately after
retrogradely injecting gold-tagged mouse serum albumin into the superior
mesenteric artery of a mouse under sublethal avertin anesthesia; the tagged
albumin is plentiful in the plasma (asterisk); no albumin is observed in the
GBM (g). (B) Enhanced image after injecting NaBH4 gold nanoparticles
comparable in size with ovalbumin; many particles (arrows) have accumu-
lated within the GBM. (C) Higher magnification unenhanced image after
injecting NaBH4 nanoparticles; the particles within the GBM have actually
accumulated close to the podocyte foot processes (f) though the podocyte
associated particles (PAPs) are some distance from the podocyte plasma
membrane. (D) Comparable magnification unenhanced image after inject-
ing NaSCN oligoclusters; the oligoclusters also associate with the podocytes.
(E, Insets) Histograms of sizes of particles in capillary plasma (outlined in red
in the representative image behind the Inset) and of the particles associated
with the podocytes (outlined in blue in the representative image); larger
particles are overrepresented in the PAPs. (F) PAPs appear as a line (blue
arrows) when viewed in cross-section although they appear as a layer when
viewed in oblique sections (red arrows).
Fig. 3. When concentrated particles are injected, clusters of PAPs accumulate
at the glomerular slits well upstream of the slit diaphragm, and the clusters can
persist for minutes to hours. (A) Unenhanced cross-section of part of a glo-
merulus 5 min after arterially injecting concentrated small NaBH4 nano-
particles. In vivo formed clusters of PAPs are seen at the podocyte slits (black
arrows) and along the bases of the foot processes (white arrow). (B) En face
view from the same kidney showing clusters along the slits. (C) Enlargement of
B showing that the number of particles in the clusters is variable. (D) Cross-
section 1 h after injecting small NaBH4 nanoparticles. A large cluster of particles
(white ellipse) is seen at this slit in a plane well upstream of the slit diaphragm
(white arrow). (E) A neighboring slit in which a few individual particles appear
in the same plane (white ellipse) well upstream of the slit diaphragm (white
arrow). No particles are close to the slit diaphragm.
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Size Discrimination by the GBM. Tests of the permeation properties
of the GBMwere made using NaSCN oligoclusters with narrow size
distributions prepared by fractionating a pool of oligoclusters on a
Superdex 200 column using PBS as the eluent buffer. On this col-
umn, fully-excluded Dextran 2000 eluted in fraction 20, and fully
penetrant acetone eluted in fraction 49. The largest particles used in
these GBM experiments eluted in fractions 22 to 24, approximately
equivalent in hydrodynamic size to IgG dimers (molecular mass 300
kDa). The intermediate-sized particles eluted in fraction 28, ap-
proximately equivalent in size to IgG monomers (molecular mass
150 kDa). The smallest particles eluted in fractions 30 and 31, ap-
proximately equivalent in size to albumin (molecular mass 66 kDa).
TEM images were obtained of the GBM and adjoining plasma in
the kidneys of mice injected intraarterially with the three sizes of
particle, followed immediately by subcapsular injection of a fixative.
The mice were pretreated with heparin to facilitate counting parti-
cles in the GBM uncluttered by the possible formation of PAPs.
Note that, although the fixative is injected with minimal delay, fix-
ation is slow compared with diffusion when submicron distances are
involved, so that the images represent the state of the GBM at
diffusion equilibrium. Fig. 4 A, B, and C shows representative images
for the three sizes of particle. Fig. 4 D, E, and F shows the distri-
butions of the particles across the GBM from the endothelium to the
podocytes, obtained by counting particles in multiple images and
assigning them to 17 bins. The large particles reached the lamina
rara interna of the GBM, but none were observed in the lamina
densa, and only 1 of 51 counted reached the lamina rara externa.
The concentration of the large particles in the lamina rara interna
was about one-third that in plasma (4.6 ± 0.4 × 10−5 particles per
unit area in lamina rara interna versus 14.7 ± 2.5 × 10−5 in upstream
plasma, P = 0.003). Some of the intermediate-sized particles per-
meated into the lamina densa although only at about one-fifth their
concentration in plasma (6.1 ± 2.1 × 10−5 particles per unit area in
the lamina densa versus 32.2 ± 5.1 × 10−5 in plasma, P < 0.001). The
smallest-sized particles permeated into all parts of the GBM, with
only a modest difference between the lamina rara interna and the
lamina densa, which was no longer obvious; their concentrations in
the lamina densa were about one-half that in plasma (9.9 ± 1.2 ×
10−4 per unit area in lamina densa versus 17.7 ± 2.5 × 10−4 in
plasma, P < 0.001). Note the deficit of particles in the bin closest to
the bases of the podocytes, supporting the postulate that permeation
into the podocyte glycocalyx is restricted. No particles, large or
small, were observed immediately upstream of the slit diaphragm.
Genetically Determined Changes in GBM Permeation. Two human
conditions in which albuminuria is caused by genetically determined
changes in the major structural components of the GBM have been
modeled in mice. One is Pierson’s syndrome (9), a congenital ne-
phrotic syndrome associated with ocular abnormalities; it is caused
by mutations in LAMB2, the gene coding for the laminin β2 subunit.
The other is Alport’s syndrome (10), a progressive nephropathy
characterized by hematuria, proteinuria, and GBM abnormalities; it
is caused by mutations in the genes coding for the α3, α4, or α5
chains of type IV collagen. Mouse models of the two conditions have
been made by disrupting the equivalent genes, Lamb2 and Col4a3
(11, 12). The Lamb2-null mice do not survive longer than a month,
but their lifespan can be extended without losing the nephrotic
syndrome if their podocytes express full-length rat laminin β2 cDNA
with a mutation analogous to the pathogenic human LAMB2-
R246Q mutation (B2LN-null) (13). Accordingly, we used these mice
in our studies.
To test whether these mutations, which affect the structure of the
GBM, alter its permeation, we used NaSCN oligoclusters prepared,
as described (6, 7), with a delay time of 60 s. The resulting oli-
goclusters were monodisperse with a size approximating that of IgG
monomers and a distribution sufficiently narrow for the oligoclusters
to be used without fractionation.
Fig. 5 A–C presents typical TEM images of the GBMs from aWT
mouse, the Pierson’s model, and the Alport’s model 2 min after tail-
vein injection of the 60-s oligoclusters. In both models, we observed
extensive disorganization and irregular increases in the thickness of
the GBM, together with segmental podocyte foot process efface-
ment. The distributions of the particles across the GBM in the three
types of mouse are presented in Fig. 5 D–F. Permeation of the oli-
goclusters into the GBM is clearly altered in the mutants; there is no
longer a region comparable with the lamina densa of WT mice that
excludes the particles, indicating that the GBM in the mutant mice is
less dense and less stratified than in theWTmouse. Fig. 5G, a plot of
the GBM/plasma concentrations at 20 different locations along the
glomerulus of a Pierson β2LN-null mouse, confirms this indication—
permeation increases in direct proportion to the local thicknesses of
the GBM (R2 = 0.53). We conclude that absence of laminin β2, or of
collagen α3(IV), major structural components of the GBM, pre-
cludes the formation of a lamina densa and allows the GBM to swell,
which increases its permeability and therefore the transglomerular
passage of macromolecules. This increased permeability and the
accompanying podocyte foot process effacement probably both
contribute to the proteinuria characteristic of the syndrome.
Saturable Capture of Filtered Particles by the Proximal Tubule. To
explore further the factors that determine whether tubular capture
of filtered nanoparticles is complete and the fate of any that are not
captured, we injected a small readily filterable NaBH4 nanoparticle
at two doses, the lower dose being one-ninth of the higher. After 10
min, urines were collected and kidneys were imaged. Fig. 6 A and B
shows that similar numbers of particles were captured and con-
centrated into intracellular vesicles by the proximal tubules of the
lower and higher dose mice, despite the ninefold difference in the
number of particles injected. In contrast, Fig. 6 C and D shows that
the number of particles reaching the collecting ducts (and therefore
the urine) was markedly dose-dependent. Thus, there were a large
number of particles in collecting ducts from the higher dose mouse,
but almost none in collecting ducts from the lower dose mouse. In
agreement with this discordance, the urine of the higher dose
mouse contained many particles whereas the urine of the low dose
mouse had none. Together, these observations demonstrate the
critical role of tubule reabsorption and its saturation in determining
whether filtered macromolecules reach the urine.
Capture of Filtered Particles by Unusual Cells and by the Slit Diaphragm.
In general, filtered particles are captured by the proximal tubules or
are excreted in the urine when tubular capture is saturated.
A B C
D E F
Fig. 4. Size discrimination by the GBM. (A) An unenhanced TEM image from a
kidney fixed immediately after intraarterially injecting fraction 22 to 24 NaSCN
oligoclusters into a heparinized mouse. The hydrodynamic size of these parti-
cles is comparable with that of IgG dimers. (B) GBM from a heparinized mouse
that had received fraction 28 NaSCN oligoclusters approximately the size of IgG
monomers. (C) GBM from a heparinized mouse that received fraction 30 and
31 NaSCN oligoclusters approximately the size of albumin. (D–F) Distributions
of the three sizes of particle across the GBM from the endothelium to the bases
of the podocytes; n, the number of particles of each size counted in the GBM.
(A–C) Asterisks, plasma; f, podocyte foot process; g, GBM.
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However, when the tubules are saturated, we have repeatedly ob-
served intercalated cells in the collecting ducts that have captured
large numbers of particles (Fig. S4A). We have also observed oc-
casional proximal tubule cells with microvilli that bind unusually
large numbers of particles (Fig. S4 B and C).
When the injected material contained very small GSH-coated
particles that pass through the glomerulus and reach the primary
filtrate, we routinely observed some particles apparently bound to the
slit diaphragm. In cross-sectional views of glomerular capillaries, they
appear as clusters at the level of the slit diaphragm (white ovals in
Fig. S5A). Oblique views show that they are actually in mono-
molecular strings (white arrows in Fig. S5B). En face views show that
the strings are located between the podocyte foot processes in a plane
sufficiently distant from other structures and shallow enough to be
imaged in a single section (Fig. S5C). The slit diaphragm apparently
has a component that can bind very small gold nanoparticles.
Discussion
In the foregoing, we have described experiments aimed at testing
whether differential permeation into the GBM and tubular reab-
sorption affect the kidney’s ability to limit the urinary excretion
of albumin and other macromolecules. We found the following.
(i) Permeation into the GBM of fluorescent-tagged macromolecules
was inversely related to their hydrodynamic size, in general agree-
ment with Ogston’s 1958 equation (2, 4) describing permeation into
gels. (ii) Parvalbumin and ovalbumin passed through the glomerulus
in amounts that saturated their capture by the tubules; uncaptured
residues reached the urine; filtered albumin and IgG were fully
captured and none reached the urine. (iii) Small negatively charged
gold nanoparticles were observed bound to a component of the
GBM close to the bases of the podocyte foot processes; heparin
prevented and disrupted this binding. (iv) When high concen-
trations of the particles were injected, aggregates of a few to
more than 20 particles were observed well upstream of the slit
diaphragm; none were close to the slit diaphragm. (v) The
aggregated podocyte-associated particles (PAPs) drifted to, but
did not clog, the podocyte slits. (vi) The PAPs persisted for hours
but were not endocytosed by the podocytes. (vii) Nanoparticles
comparable in size with IgG dimers permeated into the lamina
rara interna, but none were observed in the lamina densa. (viii)
Nanoparticles comparable with IgG monomers permeated par-
tially into the lamina densa, and some reached the lamina rara
externa. (ix) Nanoparticles comparable with albumin permeated
into all regions of the GBM, although at a lower concentration
close to the bases of the podocytes. (x) Small nanoparticles in-
jected at low concentration reached the primary filtrate but were
almost completely captured by the proximal tubules; at higher
concentrations, tubular capture was saturated and they reached
the urine. (xi) Genetic absence of laminin β2LN or collagen α3
(IV) precluded the formation of a normal GBM with a lamina
densa, thereby allowing the GBM to swell and increasing per-
meation in proportion to the swelling.
We conclude from these results that size-sensitive permeation into
the lamina densa of the GBM and the podocyte glycocalyx, together
with saturable capture by the proximal tubules, determines whether
injected macromolecules reach the urine without the need to invoke
size selection by the slit diaphragm. This conclusion agrees with that
reached by Farquhar, Palade, and coworkers from their pioneering
electron microscopic studies of the renal handling of ferritin and
dextrans (5, 14), and with Comper’s advocacy of the importance of
proximal tubules in controlling albuminuria (15). It differs drastically
from the currently widely accepted view, first advanced by Karnovsky
and coworkers, that the slit diaphragm is the primary site of size
discrimination because it has a zipper-like substructure with pores
comparable in radius with that of albumin (16, 17).
Our findings that permeation into the lamina densa increases as
hydrodynamic size decreases and that particles tend to be ex-
cluded from the podocyte glycocalyx are a strong argument for
concluding that size selection occurs in the GBM. This conclusion
does not dispute the great body of evidence demonstrating that
nephrin is required for the formation of a slit diaphragm and
normal glomerular function and that its absence in humans and in
mice leads to nephrotic levels of proteinuria (18, 19). But it does
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Fig. 5. The GBM is grossly and irregularly thickened but more permeable in
mouse models of Pierson’s and Alport’s syndromes. (A) Unenhanced image of
the GBM and adjoining plasma in the kidney of a heparinized WT mouse fixed
2 min after tail-vein injection of NaSCN oligoclusters comparable in size with
IgG dimers. The GBM (g) is uniform in thickness. (B) Unenhanced image, at the
same magnification as in A, of the GBM and adjoining plasma from a hepa-
rinized mouse model of Pierson’s syndrome. The GBM is grossly and irregularly
thickened up to three times that in WT. (C) An equivalent image from a
heparinized mouse model of Alport’s syndrome; the GBM shows the same
gross and irregular thickening of the GBM as in the Pierson’s model. (D) The
distribution of particles across the GBM from the endothelium to the bases of
the podocytes in theWT mouse. A region where the number of particles is at a
minimum, the lamina densa, is clear. (E) The distribution in the Pierson’s model;
a region of low particle density is not present. (F) The distribution in the
Alport’s model. As in the Pierson’s model, there is no region of low permeation.
(G) A plot of the ratio of the number of particles per unit area in the GBM to
the number of particles per unit area in the plasma (GMB/P) at 20 different
locations along the GBM in a Pierson-model mouse; permeation increases in
direct proportion to GBM thickness (R2 = 0.53). (A–C) Asterisks, plasma; f,
podocyte foot process; g, GBM; n, number of particles counted.
Fig. 6. Capture of filtered particles by the proximal tubule is saturable.
(A) Enhanced image of a proximal tubule fixed 10 min after i.v. injection of NaBH4
nanoparticles comparable in size with ovalbumin. Many filtered particles have been
captured by the proximal tubule microvilli (m) and concentrated into intracellular
vesicles (v). (B) A proximal tubule after injecting one-ninth the number of particles
used for A. The number of captured particles and their location is similar to that in
the higher dose mouse. (C) A collecting duct from a higher dose mouse. Many
particles are in the urinary space (u), indicating that the capacity of the upstream
proximal tubules to capture particles was saturated. (D) A collecting duct from the
lower dose mouse. Almost no particles are in the collecting duct urinary space, in-
dicating that the capacity of the upstream proximal tubules was not saturated.
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dispute the conclusion that this evidence requires that the di-
aphragm is a size-sensitive filter, and we offer an alternative in-
terpretation. Our interpretation is based on the premise that,
regardless of its porosity, the slit diaphragm is necessary for glo-
merular capillary structure—it cross-links adjacent foot processes,
fixes the width of the slits, and enables pulse pressure-sensitive
compression of the GBM. When the diaphragm is absent, the
podocyte foot processes are no longer properly conjoined, and
glomerular filtration rate (GFR) is likely to be increased. Argu-
ments have been presented elsewhere that substantially low GFRs
can lead to proteinuria (4). In the reverse direction, Lazzara and
Deen (20) have argued that substantially high GFRs can also lead
to proteinuria because a high axial flow in the proximal tubules may
leave insufficient residence time for all of the filtered protein to be
captured before it is swept past the zone of capture. We suggest that
a high GFR, rather than a failure of glomerular size selectivity, is
the reason why mice and humans lacking a normal slit diaphragm
are nephrotic. This interpretation is supported by measurements
made on the renal status of four Finnish babies, lacking nephrin,
while they were awaiting compatible kidney transplants. All had
very high GFRs (determined as clearance of inulin) (21) as follows:
girl 1 at 1 y of age had a GFR of 357 mL·min−1·1.73 m−2; girl 2 at
the age of 2.5 mo had a GFR of 223; girl 3 at 5 mo of age had a
GFR of 95; girl 4 at 0.19, 0.64, 0.90, 1.09, and 1.66 y of age had
GFRs of 137, 217, 198, 177, and 169. Normally, children will not
reach a GFR of 100 until 1 y of age [Table S2, which also reports
effective renal plasma flow (ERPF) measured as clearance of para-
aminohippuric acid (PAH) (22) and serum creatinine levels (23)]
(see also ref. 24). This interpretation of the data does not exclude
the possibility that the slit-diaphragm acts as a molecular sieve, but
it questions whether this action is required.
In summary, we have presented data showing the following: that
a variety of proteins, dextrans, and gold nanoparticles permeate into
the lamina densa in concentrations inversely related to their sizes, in
general agreement with Ogston’s well-tested gel-permeation equa-
tion; that tubular capture of filtered albumin and larger macro-
molecules normally prevents them from reaching the urine, but
tubular capture is saturated when high doses of small proteins or
small nanoparticles are injected; that permeation of gold nano-
particles into the lamina densa of the GBM and the podocyte
glycocalyx is size-sensitive; that genetic absence of laminin β2 or
collagen α3(IV), major structural proteins of the GBM, precludes
formation of a lamina densa and allows gross and irregular swelling
of the GBM, which increases permeation into the GBM in pro-
portion to the swelling. We conclude that the lamina densa of the
GBM and the podocyte glycocalyx together form the primary site of
glomerular size discrimination, but that the saturable capture of
filtered proteins and nanoparticles by the proximal tubule is critical
in determining whether they reach the urine.
Materials and Methods
Male mice from a C57BL/6 genetic background were used in all studies. In-
jections were either via a tail vein in conscious mice or retrograde through the
superior mesenteric artery of surgically prepared mice under general anes-
thesia. For general anesthesia, mice were given 0.3 to 0.5 mL of 2.5% (wt/vol)
2,2,2-tribromoethanol. The animals were handled under protocols approved
by the Institutional Animal Care and Use Committees of the University of
North Carolina at Chapel Hill. The patient studies were performed after
informed consent by the parents, and the studies were approved by the
Ethical Committee of Karolinska Institutet. Detailed protocols can be found
in SI Materials and Methods.
Fluorescent-tagged proteins and dextrans used for i.v. injection were pur-
chased from Invitrogen. They included the following: Alexafluor-488–labeled
parvalbumin, Alexafluor-555–labeled ovalbumin, Alexafluor-647–labeled BSA,
tetramethylrhodamine (TMR)-labeled 10-kDa, 40-kDa, and 70-kDa dextrans.
Protocols for synthesis of NaBH4 and NaSCN gold nanoparticles can be found
in SI Materials and Methods and refs. 6 and 7, respectively.
After injection with fluorescent-tagged proteins or dextrans, various sized
gold nanoparticles, or gold-tagged mouse serum albumin (Nanoprobes), the
left kidney was harvested and prepared for either confocal microscopy or
TEM as described in SI Materials and Methods.
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